Apatinib mesylate tablets in the treatment of refractory soft tissue sarcoma stage II, open single arm pilot study

Trial Profile

Apatinib mesylate tablets in the treatment of refractory soft tissue sarcoma stage II, open single arm pilot study

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Apatinib (Primary)
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top